based on the reports of activity of interferons against metastatic melanomas , we conducted a phase ii study of recombinant interferon alfa-2a ( roferon-a , hoffmann-la roche , nutley , nj ) in 66 patients with disseminated melanoma .
C0021747
interferons
C0021734
recombinant interferon alfa-2a